Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Basic Investigations Into Phosphomannomutase Deficiency (PMM2-CDG)

NCT03173300 is registered in ClinicalTrials.gov with Glycomine, Inc. as lead sponsor.

NCT NCT03173300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03173300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Basic Investigations Into Phosphomannomutase Deficiency (PMM2-CDG)
Lead sponsor
Glycomine, Inc.
Phase
Observational
Overall status
Completed
Start date
January 8, 2018
Completion date
April 9, 2026
Enrollment
139 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

phosphomannomutase 2 deficiency